Previous studies have demonstrated that neutrophilic inflammation and MPO activity in the lung and sputum of COPD patients correlate well with disease progression (Park et al., 2013; Zhu et al., 2014). The gene discussed is MPO; the disease is chronic obstructive pulmonary disease.